An antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof
The present disclosure relates to an antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to an antigen-binding molecule that specifically binds BCMA and CD3 and the pharmaceutical use thereof. |
---|---|
Bibliography: | Application Number: TW202211102409 |